Furthermore, the contribution of GNRH2, PRLH, GPR156, GRIK5, LHB, and CRHR2 to the neuroactive ligand-receptor interaction pathway are specified in ATLL in consistent with some other cancers [52, 53]. The gene discussed is CRHR2; the disease is adult T-cell leukemia/lymphoma.